AAR |
Area at risk |
AC |
Adenylyl cyclase |
AIP |
Autocamptide-2 Related Inhibitor Peptide |
AP |
Action potential |
APD |
Action potential duration |
ATP |
Adenosine triphosphate |
β-AR |
β-adrenoceptor |
CaMKII |
Ca2+-calmodulin-dependent protein kinase II |
CaSpF |
Calcium spark frequency |
cAMP |
3′,5′-cyclic adenosine monophosphate |
cGMP |
3′,5′-cyclic guanosine monophosphate |
8-CPT |
8-(4-chlorophenylthio)-2′-O-methyladenosine-3′,5′-cyclic monophosphate |
DAD |
Delayed afterdepolarization |
DAG |
Diacylglycerol |
DRP1 |
Dynamin related protein 1 |
EAD |
Early afterdepolarization |
ECC |
Excitation-contraction coupling |
ECG |
Electrocardiogram |
Epac |
Exchange protein directly activated by cAMP |
GAF |
cGMP-specific phosphodiesterases, adenylyl cyclases and FhlA |
HF |
Heart failure |
IP3
|
Inositol triphosphate |
ISO |
isoprenaline |
LAD |
Left anterior descending coronary artery |
LTCC |
L-type Ca2+ channel |
MI |
Myocardial infarction |
NCX |
Na+/Ca2+ exchanger |
NKA |
Na+/K+ ATPase |
NP |
Natriuretic peptide |
OE |
Overexpression/ overexpressing |
PDE |
Phosphodiesterase |
pGC |
Particulate guanylyl cyclases |
PIP2
|
Phosphatidylinositol 4,5-bisphosphate |
PKA |
Protein kinase A |
PKC |
Protein kinase C |
PKI |
Protein kinase inhibitor peptide |
PLB |
Phospholamban |
PLM |
Phospholemman |
PVC |
Premature ventricular complexes |
RyR |
Ryanodine receptors |
sAC |
Soluble adenylyl cyclases |
sAP |
Spontaneous action potential |
SCD |
Sudden cardiac death |
SERCA2 |
SR Ca2+-ATPase type-2a |
SNP |
Sodium nitroprusside |
SR |
Sarcoplasmic reticulum |
TTC |
2,3,5-triphenyltetrazolium chloride |
VES |
Ventricular extrasystoles |
WT |
Wildtype |